Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 06.04.2026 6 AIDS 1 AIDS Res Hum Retroviruses 2 BMC Cancer 1 BMC Neurol 1 BMJ 2 Clin Infect Dis 2 J Acquir Immune Defic Syndr 1 J Clin Invest 2 J Infect Dis 3 J Med Virol 3 J Virol 1 PLoS Med 11 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 3 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. CROSS S, Levi J, Venter F, Hill A, et al
   The estimated cost of MK-8527 produced at scale for once-monthly oral HIV pre-exposure prophylaxis (PrEP) in low- and middle-income countries.
   AIDS. 2026 Apr 2. doi: 10.1097/QAD.0000000000004487.
   PubMed         Abstract available
   
   
2. MASON J, Kohli M, Taiwo E, Maan I, et al
   Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV.
   AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004508.
   PubMed         Abstract available
   
   
3. GIOVENCO D, Rousseau E, Wallace M, Bekker LG, et al
   Unraveling PrEP persistence: mental health and substance use among adolescent girls and young women in a PrEP implementation program.
   AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004509.
   PubMed         Abstract available
   
   
4. GARCIA-ABELLAN J, Garcia JA, Padilla S, Fernandez-Gonzalez M, et al
   Contribution of hepatic steatosis to subclinical atherosclerosis progression in people with HIV receiving integrase inhibitors: A 5-Year prospective cohort study.
   AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004512.
   PubMed         Abstract available
   
   
5. SANTERRE M, Allen CNS, Arjona SP, Shcherbik N, et al
   HIV-1 gp120 exposure associates with mitochondrial and PKM remodeling in cardiomyocytes.
   AIDS. 2026 Mar 31. doi: 10.1097/QAD.0000000000004507.
   PubMed         Abstract available
   
   
6. FILIP I
   Can scientific innovation translate into real-world impact in the era of diversified HIV prevention choices?
   AIDS. 2026 Mar 27. doi: 10.1097/QAD.0000000000004515.
   PubMed        
   
   

   
   AIDS Res Hum Retroviruses

7. WADA NI, Chen Y, Bullotta A, Suder-Egnot N, et al
   Herpesvirus and GB Virus C Infections in Men With and Without HIV-1 Who Have Sex with Men.
   AIDS Res Hum Retroviruses. 2026 Mar 31:8892229261435255.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. ANDERA LF, Chetty DR, Mohamed Z, Oelofse D, et al
   Real-world lymphoma cohort in an HIV-endemic setting: cohort design, epidemiological features and impact of implementing novel classification standards.
   BMC Cancer. 2026 Apr 2. doi: 10.1186/s12885-026-15807.
   PubMed        
   
   
9. XU J, Zhou J, Huang X, Wu M, et al
   Comparative study of clinical features, pathology, and immunophenotype between HIV-related cutaneous and visceral Kaposi's sarcoma.
   BMC Cancer. 2026 Mar 27. doi: 10.1186/s12885-026-15910.
   PubMed        
   
   

   
   BMC Neurol

10. NOLASCO M, Pokala SS, Saavedra Forero LM, Cuevas J, et al
    Risk factors for HIV-associated neurocognitive impairment and frailty in aging people with HIV in Latin America: a systematic review.
    BMC Neurol. 2026 Apr 1. doi: 10.1186/s12883-026-04767.
    PubMed        
    
    

    
    BMJ

11. SCHUTZ E
    HIV/AIDS: MSF condemns Gilead for refusing to sell it lenacapavir.
    BMJ. 2026;393:s651.
    PubMed        
    
    

    
    Clin Infect Dis

12. ROUGET R, Valin N, Bachelard A, Palacios C, et al
    Acute Hepatitis B among PWH Switched to Long-Acting Cabotegravir/Rilpivirine: The Context Matters.
    Clin Infect Dis. 2026 Apr 3:ciag217. doi: 10.1093.
    PubMed        
    
    
13. FONCILLAS A, Ambrosioni J, de la Mora L, Mallolas J, et al
    Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.
    Clin Infect Dis. 2026 Apr 3:ciag218. doi: 10.1093.
    PubMed        
    
    

    
    J Acquir Immune Defic Syndr

14. ROLAND KB, Borkowf CB, Teplinskiy I, Almirol E, et al
    Implementation of health insurance navigation for racial/ethnic minority men who have sex with men presenting for community-based HIV testing.
    J Acquir Immune Defic Syndr. 2026 Apr 1. doi: 10.1097/QAI.0000000000003876.
    PubMed         Abstract available
    
    
15. JONES MA, Erenrich RK, Taggart T, Talan AJ, et al
    Adverse Childhood Experiences and Behaviors Associated with HIV Acquisition Among Adult Sexual Minority Men in the United States.
    J Acquir Immune Defic Syndr. 2026 Mar 31. doi: 10.1097/QAI.0000000000003875.
    PubMed         Abstract available
    
    

    
    J Clin Invest

16. MASSANELLA M, Dufour C, Pagliuzza A, Lemieux A, et al
    Rapid and profound decay of inducible and intact HIV genomes in early treated Thai children.
    J Clin Invest. 2026 Apr 2:e198054. doi: 10.1172/JCI198054.
    PubMed         Abstract available
    
    

    
    J Infect Dis

17. GOTTHOLD Z, Epstein-Shuman A, Kigozi G, Lamers SL, et al
    Pre-ART Vertical HIV-1 Transmission Risk in Uganda Varies by Sex of Child and Maternal Viral Subtype.
    J Infect Dis. 2026 Apr 2:jiag198. doi: 10.1093.
    PubMed         Abstract available
    
    
18. KOBERSSY Z, Daher J, Durieux JC, Atieh O, et al
    Comparison of Immune Activation and Gut Barrier Dysfunction between Long COVID and HIV infection.
    J Infect Dis. 2026 Mar 31:jiag146. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

19. RALLON N, Restrepo C, Manquillo A, Perez-Sanchez C, et al
    Distinctive Inflammatory Proteomic Profile of HIV-1 Elite Controllers: A Comparative Study in a Spanish Cohort.
    J Med Virol. 2026;98:e70901.
    PubMed         Abstract available
    
    
20. KONAN B, Segla R, Ong H, de Mendoza C, et al
    Infection With Human T-Lymphotropic Virus 1 (HTLV-1) in Ivory Coast.
    J Med Virol. 2026;98:e70892.
    PubMed         Abstract available
    
    
21. PASSERINI S, Mariotti D, Messina S, Mazzotta V, et al
    Prevalence and Molecular Profiling of Merkel Cell Polyomavirus in Patients With Monkeypox Virus Infection.
    J Med Virol. 2026;98:e70890.
    PubMed         Abstract available
    
    

    
    J Virol

22. NACHUM GS, Boucher JI, Flynn JM, Quansah P, et al
    Mutational scan of self-cleavage by HIV-1 protease provides new views of a conformationally dynamic mechanism.
    J Virol. 2026 Mar 31:e0222925. doi: 10.1128/jvi.02229.
    PubMed         Abstract available
    
    
23. MURPHY T, Kelly M, Shimagaki KS, DeStefanis T, et al
    Dual role of glycosylation in resistance to CD4-binding site broadly neutralizing antibodies.
    J Virol. 2026 Apr 3:e0209325. doi: 10.1128/jvi.02093.
    PubMed         Abstract available
    
    
24. CHENG D, Luo Z, Ning W, Heath SL, et al
    Systemic translocation of Staphylococcus aureus promotes autoimmunity: implications in autoantibody-mediated poor immune reconstitution from antiretroviral therapy in HIV.
    J Virol. 2026 Apr 3:e0196525. doi: 10.1128/jvi.01965.
    PubMed         Abstract available
    
    

    
    PLoS Med

25. ORTBLAD KF, Wairimu N, Culquichicon C, Njeru I, et al
    Effect of enhanced peer PrEP referral with HIV self-testing delivery among young Kenyan women: A randomized controlled trial of peer networks.
    PLoS Med. 2026;23:e1005023.
    PubMed         Abstract available
    
    

    
    PLoS One

26. ZOU Y, Sharpe A, Stratten M, Demant D, et al
    Exploring the effectiveness of podcasts in improving sexual health among young people: Findings from a qualitative study.
    PLoS One. 2026;21:e0343514.
    PubMed         Abstract available
    
    
27. BUDHA K, Ghimire P
    Health-related quality of life in children with HIV/AIDS: Child and parent perspectives at a tertiary ART clinic in Kathmandu, Nepal.
    PLoS One. 2026;21:e0346012.
    PubMed         Abstract available
    
    
28. MLAMBO LM, Milovanovic M, Hanrahan CF, Motsomi K, et al
    The impact of ethical implications intertwined with tuberculosis household contact investigation: A qualitative study.
    PLoS One. 2026;21:e0306848.
    PubMed         Abstract available
    
    
29. NATURINDA K, Biraro IA, Mupere E, Muyunga A, et al
    Prevalence, perceptions and factors associated with non-adherence to hepatotoxicity monitoring among people living with HIV on tuberculosis preventive treatment at Mulago ISS clinic.
    PLoS One. 2026;21:e0345662.
    PubMed         Abstract available
    
    
30. JUGA AJC, Hens N, Osman N, Aerts M, et al
    Joint modelling of left- and interval-censored viral load for couples in Mozambique.
    PLoS One. 2026;21:e0345307.
    PubMed         Abstract available
    
    
31. 
    Editorial Note: Cumulative burden of non-communicable diseases predicts COVID hospitalization among people with HIV: A one-year retrospective cohort study.
    PLoS One. 2026;21:e0346212.
    PubMed        
    
    
32. HOLT L, Corneli A, Stevenson E, Swartz JJ, et al
    The theoretical understanding of risk perception and dual-method contraceptive decision-making among Texas adolescent and young adult cisgender females.
    PLoS One. 2026;21:e0343687.
    PubMed         Abstract available
    
    
33. SANDE L, Benade M, Tchereni T, Kamanga A, et al
    Facility-level integration of hypertension and diabetes services with HIV treatment in sub-Saharan Africa: Observational evidence from Malawi, South Africa, and Zambia.
    PLoS One. 2026;21:e0346029.
    PubMed         Abstract available
    
    
34. ARNS-GLASER L, Farnham A, Hochstrasser K, Fehr JS, et al
    Lowering the barriers to sexual health services: Impacts of free counselling and testing for sexually transmitted infections in Switzerland - an observational study.
    PLoS One. 2026;21:e0327114.
    PubMed         Abstract available
    
    
35. BANDA-MTAULA GT, Simiyu I, Salimu SN, Spencer SA, et al
    Perspectives on multimorbidity care provision among public hospital-based healthcare workers in Blantyre and Chiradzulu, Malawi: A qualitative study.
    PLoS One. 2026;21:e0346493.
    PubMed         Abstract available
    
    
36. KATZ DA, Copen CE, Haderxhanaj LT, Hogben M, et al
    Changes in sexual behaviors, network attributes, and STI testing among 15-44-year-olds by marital/cohabiting status and partner number: National Survey of Family Growth, 2008-19.
    PLoS One. 2026;21:e0343813.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

37. VUONG HR, Zhou Q, L Lesko S, Tenneti K, et al
    The biased adenosine-rich content of the HIV-1 genome serves as a molecular signature that facilitates efficient packaging.
    Proc Natl Acad Sci U S A. 2026;123:e2522851123.
    PubMed         Abstract available
    
    

    
    Science

38. COHEN J
    Is a heralded U.S. effort to help the world battle HIV facing extinction?
    Science. 2026;392:15-16.
    PubMed         Abstract available
    
    

    
    Vaccine

39. VAN DE BURGWAL LHM, Pronker ES, Herz J
    Australia's vaccine legacy: Time for a boost? Mapping an innovation system in a fragmented data environment.
    Vaccine. 2026;80:128525.
    PubMed         Abstract available
    
    
40. CALLEWAERT K, Lavreys L, Willems W, van Rosmalen MGM, et al
    Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials.
    Vaccine. 2026;79:128500.
    PubMed         Abstract available
    
    
41. YANG S, Dai D, Kang Z, Zhang L, et al
    Immunogenicity and safety of a quadrivalent recombinant human papillomavirus vaccine (type 6/11/16/18) (Hansenula polymorpha): A randomized controlled phase 2 non-inferiority clinical trial.
    Vaccine. 2026;80:128527.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum